Bombay Super Hybrid Seeds Q2: margins compress sharply, PAT growth of 5% lags revenue surge
PAT +5.14% YoY · revenue +219.8% · margins compressing
₹85.86 Cr
+219.8% YoY
₹2.36 Cr
+5.14% YoY
2.75%
₹0.22
Bombay Super Hybrid Seeds' standalone revenue rose 219.8% YoY to ₹85.86 Cr in Q2 FY27 (vs ₹26.85 Cr in Q2 FY26), but standalone PAT grew just 5.1% YoY to ₹2.36 Cr (vs ₹2.24 Cr) — net profit margin fell to 2.75% from 8.36%, and EBITDA-level margin (PBT + finance cost + depreciation ÷ revenue) fell to roughly 4.6% from ~15.6% a year ago. Sequentially, revenue fell 52.97% and PAT fell 83.5% from Q1 FY27 (revenue ₹182.57 Cr, PAT ₹14.30 Cr); this QoQ drop is treated as a seasonality artifact of the hybrid-seed business, where sales concentrate ahead of the kharif sowing window in Q1, rather than as fresh weakness — the YoY comparison is the one that matters here.
Q2 FY-2027 vs prior quarters
No year-ago quarter on record — YoY cells may be blank.
The gap between the 220% YoY revenue jump and the 5% PAT growth shows the incremental volume carried very thin margin this quarter: total expenses rose to ₹83.01 Cr from ₹24.49 Cr a year ago, driven by purchases/production costs and the change-in-inventories line scaling roughly in step with the higher sales base, while employee costs and depreciation rose only modestly and finance costs stayed close to last year's level. There is no exceptional item on either side of the YoY comparison, so the margin compression is read as operating, not accounting.
The stock went into the print at ₹99, up 15.9% over the past month of trading.
What the summary numbers don't show
No exceptional items in the current or year-ago quarter — auditor Gautam N Associates issued an unmodified review opinion on the unaudited standalone results.
There is no analyst coverage or consensus estimate for this stock (confirmed via search), so no beat/miss call versus street can be made, and the company has no formal guidance on record in our context or found via search, so management's own bar cannot be checked either. No results press release was available for this filing to cross-check management's framing. The quarter's other disclosed developments — a ₹3.68 Cr Indore property acquisition in August and the FY26 annual report submission/AGM approvals through September-October — are governance and capacity items that have not yet shown up in this quarter's P&L.
W1
Whether Q3 FY27 margins recover toward the Q1 FY27 levels (NPM ~7.8%, EBITDA margin ~9.4%) or stay compressed near this quarter's ~2.7%/4.6%.
W2
Full-year FY27 pace: H1 PAT of ₹16.66 Cr is already ~62.5% of FY26's full-year PAT of ₹26.66 Cr, so H2 trends will decide whether the year tracks ahead despite the Q2 squeeze.
W3
Working-capital unwind: inventories fell from ₹232.07 Cr to ₹102.43 Cr and current borrowings dropped from ₹106.60 Cr to nil over H1 — watch whether this reverses with the next sowing-season inventory build.
Only standalone statement filed (no consolidated section). Figures in ₹ Lakhs in source, converted to ₹ Cr (÷100). No exceptional items in current or year-ago quarter; totalIncome and PAT tie out exactly to the filing.